Baxter International Inc
BAX19.160USD
-3.260-14.54%
收盤 10/30, 16:00（美東）報價延遲15分鐘
9.84B總市值
虧損本益比TTM
關於 Baxter International Inc 公司
百特國際公司是一家全球醫療科技公司。其部門包括醫療產品和療法、醫療保健系統和技術以及製藥。醫療產品和療法部門包括其無菌靜脈注射液、輸液系統、給藥裝置、腸外營養療法和手術止血劑、密封劑和防粘連產品的銷售。醫療保健系統和技術部門包括其互聯護理解決方案和協作工具的銷售，包括智能牀系統、患者監測系統和診斷技術、呼吸健康設備和先進的手術空間設備，包括手術室集成技術、精密定位設備和其他配件。製藥部門包括特種注射藥物、吸入麻醉和藥物配製的銷售。它提供診斷、重症監護、營養、醫院和外科產品組合。
Baxter International Inc簡介
公司代碼BAX
公司名稱Baxter International Inc
上市日期May 15, 1961
CEOMr. Andrew P. Hider
員工數量38000
證券類型Ordinary Share
年結日May 15
公司地址One Baxter Parkway
城市DEERFIELD
上市交易所NYSE Consolidated
國家United States of America
郵編60015
電話12249482000
網址https://www.baxter.com/
公司代碼BAX
上市日期May 15, 1961
CEOMr. Andrew P. Hider
Baxter International Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
--
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
127.11K
-2.45%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-14.01%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+31.17%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
22.94K
+45.58%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+77.49%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
10.65K
+206.88%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
7.97K
+912.71%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
--
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
127.11K
-2.45%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-14.01%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+31.17%
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Infusion Therapies and Technologies
1.02B
36.44%
Care and Connectivity Solutions
474.00M
16.87%
Injectables and Anesthesia
332.00M
11.81%
Advanced Surgery
296.00M
10.53%
Front Line Care
293.00M
10.43%
其他
391.00M
13.91%
地區USD
名稱
營收
佔比
United States
1.54B
54.66%
International
1.27B
45.34%
業務
地區
業務USD
名稱
營收
佔比
Infusion Therapies and Technologies
1.02B
36.44%
Care and Connectivity Solutions
474.00M
16.87%
Injectables and Anesthesia
332.00M
11.81%
Advanced Surgery
296.00M
10.53%
Front Line Care
293.00M
10.43%
其他
391.00M
13.91%
股東統計
更新時間: 8月19日 週二
更新時間: 8月19日 週二
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.06%
Pzena Investment Management, LLC
10.80%
Dodge & Cox
10.15%
BlackRock Institutional Trust Company, N.A.
5.81%
State Street Investment Management (US)
4.27%
其他
56.91%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
12.06%
Pzena Investment Management, LLC
10.80%
Dodge & Cox
10.15%
BlackRock Institutional Trust Company, N.A.
5.81%
State Street Investment Management (US)
4.27%
其他
56.91%
股東類型
持股股東
佔比
Investment Advisor/Hedge Fund
46.91%
Investment Advisor
44.27%
Hedge Fund
3.08%
Research Firm
2.19%
Pension Fund
1.76%
Insurance Company
1.45%
Bank and Trust
1.27%
Sovereign Wealth Fund
1.14%
Individual Investor
0.46%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1777
523.70M
101.96%
-17.42M
2025Q2
1877
507.74M
98.85%
-23.16M
2025Q1
1934
508.09M
99.01%
-37.41M
2024Q4
1984
501.11M
97.98%
-41.68M
2024Q3
2005
485.40M
95.14%
-42.32M
2024Q2
2042
472.72M
92.77%
-47.98M
2024Q1
2091
469.13M
92.11%
-57.76M
2023Q4
2137
471.69M
92.98%
-44.04M
2023Q3
2123
465.39M
91.91%
-35.52M
2023Q2
2140
458.55M
90.66%
-30.65M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
61.95M
12.06%
+1.13M
+1.85%
Jun 30, 2025
Pzena Investment Management, LLC
55.46M
10.8%
+16.12M
+40.98%
Aug 31, 2025
Dodge & Cox
52.12M
10.15%
+662.70K
+1.29%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
29.85M
5.81%
-423.57K
-1.40%
Jun 30, 2025
State Street Investment Management (US)
21.94M
4.27%
+170.66K
+0.78%
Jun 30, 2025
T. Rowe Price Associates, Inc.
21.21M
4.13%
+1.64M
+8.40%
Jun 30, 2025
BlackRock Financial Management, Inc.
18.73M
3.65%
+742.99K
+4.13%
Jun 30, 2025
Geode Capital Management, L.L.C.
12.88M
2.51%
+326.65K
+2.60%
Jun 30, 2025
Harris Associates L.P.
9.35M
1.82%
+344.54K
+3.83%
Jun 30, 2025
BlackRock Investment Management, LLC
7.81M
1.52%
+818.08K
+11.70%
Jun 30, 2025
查看更多
持股ETF
更新時間: 10月6日 週一
更新時間: 10月6日 週一
機構名稱
佔比
iShares Large Cap Value Active ETF
2.23%
First Trust Indxx Medical Devices ETF
1.6%
iShares U.S. Medical Devices ETF
1.45%
SPDR S&P Health Care Equipment ETF
1.42%
Invesco S&P 500 Equal Weight Health Care ETF
1.29%
Humankind US Stock ETF
1.04%
VanEck Morningstar SMID Moat ETF
0.95%
Point Bridge America First ETF
0.72%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.66%
Gotham 1000 Value ETF
0.46%
查看更多
iShares Large Cap Value Active ETF
佔比2.23%
First Trust Indxx Medical Devices ETF
佔比1.6%
iShares U.S. Medical Devices ETF
佔比1.45%
SPDR S&P Health Care Equipment ETF
佔比1.42%
Invesco S&P 500 Equal Weight Health Care ETF
佔比1.29%
Humankind US Stock ETF
佔比1.04%
VanEck Morningstar SMID Moat ETF
佔比0.95%
Point Bridge America First ETF
佔比0.72%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
佔比0.66%
Gotham 1000 Value ETF
佔比0.46%
分紅派息
近5年累計派現
2.75B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
Feb 12, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option
Mar 01, 2024
Apr 01, 2024
Feb 29, 2024
Nov 14, 2023
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option
Dec 01, 2023
Jan 02, 2024
Nov 30, 2023
Jul 18, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option
Sep 01, 2023
Oct 02, 2023
Aug 31, 2023
May 01, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jul 03, 2023
Jun 01, 2023
Feb 14, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option
Feb 24, 2023
Apr 03, 2023
Feb 23, 2023
Nov 15, 2022
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022
Dec 02, 2022
Jan 03, 2023
Dec 01, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
